R
Ultragenyx Pharmaceutical Inc.
RARE · NASDAQ · Healthcare · 2.6B
Price · close
$25.83
+2.01% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
—
Enterprise value / EBITDAEV/EBITDA
-7.1×
Free cash flow yieldFCF yield
-18.5%
Return on equityROE
718.8%
Operating margin
-79.5%
Net debt / EBITDAbalance-sheet strength
-1.8×
Interest coverage
-8.6×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.